Report Detail
Global Traveler’s Diarrhea Treatment Market Growth 2019-2024
- RnM2774226 |
- 17 January, 2019 |
- Global |
- 135 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.
According to this study, over the next five years the Traveler’s Diarrhea Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Traveler’s Diarrhea Treatment business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Traveler’s Diarrhea Treatment market by product type, application, key manufacturers and key regions and countries.
This study considers the Traveler’s Diarrhea Treatment value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2024 in section 11.7.
Immunization
Non-antibiotic Agents
Antibiotics
Anti-Motility Agents
Other
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2024 in section 11.8.
Adult Traveler's Diarrhea
Children Traveler's Diarrhea
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Salix Pharmaceuticals
P&G
Johnson & Johnson
Otsuka Pharma
Valneva
Shanghai United Cell
PaxVax
Livzon
Immuron
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Traveler’s Diarrhea Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2024.
To understand the structure of Traveler’s Diarrhea Treatment market by identifying its various subsegments.
Focuses on the key global Traveler’s Diarrhea Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Traveler’s Diarrhea Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Traveler’s Diarrhea Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2018-2023 Global Traveler’s Diarrhea Treatment Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Traveler’s Diarrhea Treatment Consumption 2013-2023
- 2.1.2 Traveler’s Diarrhea Treatment Consumption CAGR by Region
- 2.2 Traveler’s Diarrhea Treatment Segment by Type
- 2.2.1 Immunization
- 2.2.2 Non-antibiotic Agents
- 2.2.3 Antibiotics
- 2.2.4 Anti-Motility Agents
- 2.2.5 Other
- 2.3 Traveler’s Diarrhea Treatment Consumption by Type
- 2.3.1 Global Traveler’s Diarrhea Treatment Consumption Market Share by Type (2013-2018)
- 2.3.2 Global Traveler’s Diarrhea Treatment Revenue and Market Share by Type (2013-2018)
- 2.3.3 Global Traveler’s Diarrhea Treatment Sale Price by Type (2013-2018)
- 2.4 Traveler’s Diarrhea Treatment Segment by Application
- 2.4.1 Adult Traveler's Diarrhea
- 2.4.2 Children Traveler's Diarrhea
- 2.5 Traveler’s Diarrhea Treatment Consumption by Application
- 2.5.1 Global Traveler’s Diarrhea Treatment Consumption Market Share by Application (2013-2018)
- 2.5.2 Global Traveler’s Diarrhea Treatment Value and Market Share by Application (2013-2018)
- 2.5.3 Global Traveler’s Diarrhea Treatment Sale Price by Application (2013-2018)
3 Global Traveler’s Diarrhea Treatment by Players
- 3.1 Global Traveler’s Diarrhea Treatment Sales Market Share by Players
- 3.1.1 Global Traveler’s Diarrhea Treatment Sales by Players (2016-2018)
- 3.1.2 Global Traveler’s Diarrhea Treatment Sales Market Share by Players (2016-2018)
- 3.2 Global Traveler’s Diarrhea Treatment Revenue Market Share by Players
- 3.2.1 Global Traveler’s Diarrhea Treatment Revenue by Players (2016-2018)
- 3.2.2 Global Traveler’s Diarrhea Treatment Revenue Market Share by Players (2016-2018)
- 3.3 Global Traveler’s Diarrhea Treatment Sale Price by Players
- 3.4 Global Traveler’s Diarrhea Treatment Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Traveler’s Diarrhea Treatment Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Traveler’s Diarrhea Treatment Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Traveler’s Diarrhea Treatment by Regions
- 4.1 Traveler’s Diarrhea Treatment by Regions
- 4.1.1 Global Traveler’s Diarrhea Treatment Consumption by Regions
- 4.1.2 Global Traveler’s Diarrhea Treatment Value by Regions
- 4.2 Americas Traveler’s Diarrhea Treatment Consumption Growth
- 4.3 APAC Traveler’s Diarrhea Treatment Consumption Growth
- 4.4 Europe Traveler’s Diarrhea Treatment Consumption Growth
- 4.5 Middle East & Africa Traveler’s Diarrhea Treatment Consumption Growth
5 Americas
- 5.1 Americas Traveler’s Diarrhea Treatment Consumption by Countries
- 5.1.1 Americas Traveler’s Diarrhea Treatment Consumption by Countries (2013-2018)
- 5.1.2 Americas Traveler’s Diarrhea Treatment Value by Countries (2013-2018)
- 5.2 Americas Traveler’s Diarrhea Treatment Consumption by Type
- 5.3 Americas Traveler’s Diarrhea Treatment Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Traveler’s Diarrhea Treatment Consumption by Countries
- 6.1.1 APAC Traveler’s Diarrhea Treatment Consumption by Countries (2013-2018)
- 6.1.2 APAC Traveler’s Diarrhea Treatment Value by Countries (2013-2018)
- 6.2 APAC Traveler’s Diarrhea Treatment Consumption by Type
- 6.3 APAC Traveler’s Diarrhea Treatment Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Traveler’s Diarrhea Treatment by Countries
- 7.1.1 Europe Traveler’s Diarrhea Treatment Consumption by Countries (2013-2018)
- 7.1.2 Europe Traveler’s Diarrhea Treatment Value by Countries (2013-2018)
- 7.2 Europe Traveler’s Diarrhea Treatment Consumption by Type
- 7.3 Europe Traveler’s Diarrhea Treatment Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Traveler’s Diarrhea Treatment by Countries
- 8.1.1 Middle East & Africa Traveler’s Diarrhea Treatment Consumption by Countries (2013-2018)
- 8.1.2 Middle East & Africa Traveler’s Diarrhea Treatment Value by Countries (2013-2018)
- 8.2 Middle East & Africa Traveler’s Diarrhea Treatment Consumption by Type
- 8.3 Middle East & Africa Traveler’s Diarrhea Treatment Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.2 Traveler’s Diarrhea Treatment Distributors
- 10.3 Traveler’s Diarrhea Treatment Customer
11 Global Traveler’s Diarrhea Treatment Market Forecast
- 11.1 Global Traveler’s Diarrhea Treatment Consumption Forecast (2018-2023)
- 11.2 Global Traveler’s Diarrhea Treatment Forecast by Regions
- 11.2.1 Global Traveler’s Diarrhea Treatment Forecast by Regions (2018-2023)
- 11.2.2 Global Traveler’s Diarrhea Treatment Value Forecast by Regions (2018-2023)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Traveler’s Diarrhea Treatment Forecast by Type
- 11.8 Global Traveler’s Diarrhea Treatment Forecast by Application
12 Key Players Analysis
- 12.1 Salix Pharmaceuticals
- 12.1.1 Company Details
- 12.1.2 Traveler’s Diarrhea Treatment Product Offered
- 12.1.3 Salix Pharmaceuticals Traveler’s Diarrhea Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
- 12.1.4 Main Business Overview
- 12.1.5 Salix Pharmaceuticals News
- 12.2 P&G
- 12.2.1 Company Details
- 12.2.2 Traveler’s Diarrhea Treatment Product Offered
- 12.2.3 P&G Traveler’s Diarrhea Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
- 12.2.4 Main Business Overview
- 12.2.5 P&G News
- 12.3 Johnson & Johnson
- 12.3.1 Company Details
- 12.3.2 Traveler’s Diarrhea Treatment Product Offered
- 12.3.3 Johnson & Johnson Traveler’s Diarrhea Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
- 12.3.4 Main Business Overview
- 12.3.5 Johnson & Johnson News
- 12.4 Otsuka Pharma
- 12.4.1 Company Details
- 12.4.2 Traveler’s Diarrhea Treatment Product Offered
- 12.4.3 Otsuka Pharma Traveler’s Diarrhea Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
- 12.4.4 Main Business Overview
- 12.4.5 Otsuka Pharma News
- 12.5 Valneva
- 12.5.1 Company Details
- 12.5.2 Traveler’s Diarrhea Treatment Product Offered
- 12.5.3 Valneva Traveler’s Diarrhea Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
- 12.5.4 Main Business Overview
- 12.5.5 Valneva News
- 12.6 Shanghai United Cell
- 12.6.1 Company Details
- 12.6.2 Traveler’s Diarrhea Treatment Product Offered
- 12.6.3 Shanghai United Cell Traveler’s Diarrhea Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
- 12.6.4 Main Business Overview
- 12.6.5 Shanghai United Cell News
- 12.7 PaxVax
- 12.7.1 Company Details
- 12.7.2 Traveler’s Diarrhea Treatment Product Offered
- 12.7.3 PaxVax Traveler’s Diarrhea Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
- 12.7.4 Main Business Overview
- 12.7.5 PaxVax News
- 12.8 Livzon
- 12.8.1 Company Details
- 12.8.2 Traveler’s Diarrhea Treatment Product Offered
- 12.8.3 Livzon Traveler’s Diarrhea Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
- 12.8.4 Main Business Overview
- 12.8.5 Livzon News
- 12.9 Immuron
- 12.9.1 Company Details
- 12.9.2 Traveler’s Diarrhea Treatment Product Offered
- 12.9.3 Immuron Traveler’s Diarrhea Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
- 12.9.4 Main Business Overview
- 12.9.5 Immuron News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Traveler’s Diarrhea Treatment. Industry analysis & Market Report on Traveler’s Diarrhea Treatment is a syndicated market report, published as Global Traveler’s Diarrhea Treatment Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Traveler’s Diarrhea Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
